Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The PsiFI Trial
NCT07861217Phase 2Not yet recruiting
- Sponsor
- Rigshospitalet
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga FAPI-46 in sarcoma, sponsored by Rigshospitalet. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
68Ga FAPI-46
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT07861217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07861217.